Anuh Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 141.63 | 166.71 | 175.76 |
| Operating Expense | 127.34 | 144.67 | 148.11 |
| Net Profit | 9.51 | 15.36 | 19.11 |
| Net Profit Margin | 6.71 | 9.21 | 10.87 |
| Earning Per Share | 1.90 | 3.06 | 3.81 |
| EBIDTA | 14.25 | 22.27 | 27 |
| Effective Tax Rate | 19.03 | 20.77 | 20.07 |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 141.63 |
| Operating Expense | 127.34 |
| Net Profit | 9.51 |
| Net Profit Margin | 6.71 |
| Earning Per Share | 1.90 |
| EBIDTA | 14.25 |
| Effective Tax Rate | 19.03 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 647.00 | 527.49 | 486.65 |
| Operating Expenses Annual | 571.86 | 476.21 | 439.80 |
| Operating Profit Annual | 87.25 | 57.39 | 52.04 |
| Interest Annual | 0.35 | 0.22 | 0.96 |
| Depreciation | 8.58 | 9.70 | 11.96 |
| Net Profit Annual | 60.06 | 36.18 | 30.56 |
| Tax Annual | 18.25 | 11.29 | 8.56 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 647.00 |
| Operating Expenses Annual | 571.86 |
| Operating Profit Annual | 87.25 |
| Interest Annual | 0.35 |
| Depreciation | 8.58 |
| Net Profit Annual | 60.06 |
| Tax Annual | 18.25 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.93 | 3.80 | 2.20 |
| Cash Flow from Operations | 12.93 | 53.90 | 28.86 |
| Cash Flow from Investing | 0.92 | -43.48 | -7.82 |
| Cash Flow from Financing | -8.57 | -12.29 | -19.45 |
| Cash Flow at the End | 7.20 | 1.93 | 3.80 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 1.93 |
| Cash Flow from Operations | 12.93 |
| Cash Flow from Investing | 0.92 |
| Cash Flow from Financing | -8.57 |
| Cash Flow at the End | 7.20 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 11.92 | 10.98 | 10.82 |
| PBIT Margin (%) | 10.60 | 9.14 | 8.36 |
| PBT Margin (%) | -0.44 | -3.05 | 3.07 |
| Net PROFIT Margin (%) | 9.28 | 6.86 | 6.28 |
| Return On Networth / Equity (%) | 19.49 | 15.90 | 15.11 |
| Return On Networth /Employed (%) | 25.44 | 20.82 | 19.14 |
| Return On Assets (%) | 22.28 | 15.64 | 14.38 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.04 |
| Asset Turnover Ratio (%) | 2.40 | 2.28 | 2.29 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 11.92 |
| PBIT Margin (%) | 10.60 |
| PBT Margin (%) | -0.44 |
| Net PROFIT Margin (%) | 9.28 |
| Return On Networth / Equity (%) | 19.49 |
| Return On Networth /Employed (%) | 25.44 |
| Return On Assets (%) | 22.28 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 2.40 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 48.95 | 52.81 | 61.42 |
| Total Current Assets Annual | 336.20 | 307.61 | 258.69 |
| Non Current Assets Annual | 109.48 | 97.37 | 88.49 |
| Total Shareholders Funds Annual | 291.22 | 241.22 | 213.77 |
| Total Assets Annual | 445.68 | 404.98 | 347.17 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 48.95 |
| Total Current Assets Annual | 336.20 |
| Non Current Assets Annual | 109.48 |
| Total Shareholders Funds Annual | 291.22 |
| Total Assets Annual | 445.68 |
No Data Availabe
